NovoCure Q3 EPS $(0.09) Beats $(0.24) Estimate, Sales $193.399M Beat $182.233M Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings Beats
NovoCure (NASDAQ:NVCR) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.24) by 62.5 percent. This is a 72.73 percent increase over losses of $(0.33) per share from the same
NovoCure (NASDAQ:NVCR) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.24) by 62.5 percent. This is a 72.73 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $193.399 million which beat the analyst consensus estimate of $182.233 million by 6.13 percent. This is a 15.67 percent increase over sales of $167.204 million the same period last year.